1990
DOI: 10.1021/jm00164a042
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis, brain uptake, and pharmacological properties of a glyceryl lipid containing GABA and the GABA-T inhibitor .gamma.-vinyl-GABA

Abstract: 1-O-Linolenoyl-2-O-(4-aminobutyryl)-3-O-(4-vinyl-4-aminobutyryl)glycerol (LGV) was synthesized as an example of a prodrug which readily penetrates the blood-brain barrier (brain penetration index 97% +/- 15%) and releases two active substances in the central nervous system (CNS): GABA (4-aminobutanoic acid) and the GABA transaminase inhibitor (GABA-T) of GABA breakdown. In vitro studies showed that the compound can inhibit GABA-T after hydrolysis by CNS esterases and that it enhanced GABAergic inhibition when … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
13
0

Year Published

1992
1992
2021
2021

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 54 publications
(13 citation statements)
references
References 3 publications
(4 reference statements)
0
13
0
Order By: Relevance
“…25 Another related approach for anticonvulsant drug design was the synthesis of a glyceryl lipid (8.18, R = linolenoyl) containing one GABA molecule and one vigabatrin molecule, a mechanism-based inactivator of GABA amino-transferase and anticonvulsant drug (see Section V,C,3,a of Chapter 5). 26 This compound inactivates GABA aminotransferase in vitro only if brain esterases are added to cleave the vigabatrin from the glyceryl lipid. It also is 300 times more potent than vigabatrin, in vivo, presumably because of its increased ability to enter the brain.…”
Section: Bîfcmentioning
confidence: 99%
“…25 Another related approach for anticonvulsant drug design was the synthesis of a glyceryl lipid (8.18, R = linolenoyl) containing one GABA molecule and one vigabatrin molecule, a mechanism-based inactivator of GABA amino-transferase and anticonvulsant drug (see Section V,C,3,a of Chapter 5). 26 This compound inactivates GABA aminotransferase in vitro only if brain esterases are added to cleave the vigabatrin from the glyceryl lipid. It also is 300 times more potent than vigabatrin, in vivo, presumably because of its increased ability to enter the brain.…”
Section: Bîfcmentioning
confidence: 99%
“…17 Several approaches have been taken to increase the brain concentrations of GABA. One approach has been to make prodrugs of GABA, 18,19 but except for progabide, this has not been highly successful. Another approach taken to increase brain GABA levels is the use of a compound that crosses the blood-brain barrier and then inhibits or inactivates GABA-AT, the enzyme that degrades GABA.…”
Section: Introductionmentioning
confidence: 99%
“…It is considered to act as a natural calming and anti-epileptic agent in the brain. Since GABA is not transported efficiently into the brain from the bloodstream, most GABA found in the brain is manufactured there [184][185][186][187][188][189][190][191][192][193][194][195].…”
Section: Schiff Bases As Gabamimeticsmentioning
confidence: 99%
“…(Scheme 20) [195][196]. Fengabine (239) is also a Schiff base and acts as an [121,168] 216 [121,168] 217 [121,168] 222 [163] 223 [163] 218 [163] 224 [163] 225 [163] 219 [163] O O S NH [197][198][199][200].…”
Section: Schiff Bases As Gabamimeticsmentioning
confidence: 99%